Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies

High Tide

Market Cap: CA$285.6m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Cresco Labs

Market Cap: CA$526.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Bausch Health Companies

Market Cap: CA$1.8b

Operates as a diversified specialty pharmaceutical and medical device company.

Planet 13 Holdings

Market Cap: CA$65.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Curaleaf Holdings

Market Cap: CA$3.9b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Aurora Cannabis

Market Cap: CA$253.3m

Engages in the production, distribution, and sale of cannabis products in Canada and internationally.

MariMed

Market Cap: CA$27.1m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Jushi Holdings

Market Cap: CA$92.8m

Engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States.

Green Thumb Industries

Market Cap: CA$2.4b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Medexus Pharmaceuticals

Market Cap: CA$162.7m

Operates as a pharmaceutical company in Canada and the United States.

Bright Minds Biosciences

Market Cap: CA$935.0m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Tilray Brands

Market Cap: CA$551.1m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Verano Holdings

Market Cap: CA$600.5m

Engages in the cannabis business in the United States.

Rubicon Organics

Market Cap: CA$30.7m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

TerrAscend

Market Cap: CA$339.5m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Organigram Global

Market Cap: CA$204.1m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Auxly Cannabis Group

Market Cap: CA$250.9m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.

SOL Global Investments

Market Cap: CA$1.1m

A private equity firm specializing in emerging growth.

Vext Science

Market Cap: CA$55.7m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Novartis

Market Cap: CA$229.0b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Avant Brands

Market Cap: CA$8.9m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Vireo Growth

Market Cap: CA$644.9m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

1933 Industries

Market Cap: CA$5.2m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Thermo Fisher Scientific

Market Cap: CA$192.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Gilead Sciences

Market Cap: CA$163.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Fennec Pharmaceuticals

Market Cap: CA$371.7m

Operates as a commercial stage biopharmaceutical company in the United States.

Pfizer

Market Cap: CA$138.6b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Eli Lilly

Market Cap: CA$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Roche Holding

Market Cap: CA$264.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

CordovaCann

Market Cap: CA$3.6m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

Cybin

Market Cap: CA$365.1m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

Sanofi

Market Cap: CA$89.4b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Amgen

Market Cap: CA$201.9b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.